Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
| Title |
Grant Type
Sort ascending
|
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Cancer Registry
Release Date:
|
Research | Oncology | Congo, The Democratic Republic | |
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
|
Research | Rare Disease | Australia, Canada, France, Germany, Italy, Japan, Korea, Spain | |
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
|
Research | Inflammation & Immunology | China | |
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
|
Research | Inflammation & Immunology | China | |
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
|
Quality Improvement | Oncology | Canada | |
Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
Release Date:
|
Quality Improvement | Vaccines | Italy | |
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
|
Quality Improvement | Rare Disease | Canada | |
Projects for Enhancing Regional Cancer Treatment
Release Date:
Partner: Japanese Society of Clinical Oncology
|
Quality Improvement | Oncology | Japan | |
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
|
Quality Improvement | Rare Disease | USA | |
2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
|
Quality Improvement | Rare Disease | All | |
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
|
Quality Improvement | Oncology | Spain | |
Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Release Date:
Partner: Colorectal Cancer Canada (CCC)
|
Quality Improvement | Oncology | Canada |
| Title |
Grant Type
Sort ascending
|
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
2022/2023 Global NASH ASPIRE
Release Date:
|
Research | Internal Medicine | All | |
2022/2023 Global Obesity ASPIRE
Release Date:
|
Research | Internal Medicine | All | |
Invasive Fungal Infections Research in China
Release Date:
|
Research | Inflammation & Immunology | China | |
Review and Analysis of Retrospective, Local Source, Serotype Distribution for Invasive Pneumococcal Disease in Latin America
Release Date:
|
Research | Vaccines | All | |
Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal disease
Release Date:
|
Research | Vaccines | Algeria, Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Morocco, Oman, Qatar, Saudi Arabia, Tunisia, United Arab Emirates | |
Meta-analysis of COVID-19 Vaccine Hesitancy Behavioral & Social Science Research
Release Date:
|
Research | Vaccines | USA | |
2022 Growth Hormone Research
Release Date:
|
Research | Rare Disease | All | |
Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal disease
Release Date:
|
Research | Vaccines | Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam | |
Growth Hormone Research- United States
Release Date:
|
Research | Rare Disease | USA | |
Early Diagnosis of Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)
Release Date:
|
Research | Hospital | All | |
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
Release Date:
|
Research | Rare Disease | All | |
ASTRO-Myovant Sciences-Pfizer Alliance New Combination Therapy Challenge
Release Date:
Partner: ASTRO and Myovant Sciences
|
Research | Oncology | USA |